Valuation: Alpha IVF Group

Market Cap 1.36B 332M 286M 269M 245M 460M 31.71B 468M 3.15B 1.23B 15.88B 1.25B 1.22B 52.77B P/E 2026
22.7x
P/E 2027 * 20.7x
Enterprise Value 1.36B 332M 286M 269M 245M 460M 31.71B 468M 3.15B 1.23B 15.88B 1.25B 1.22B 52.77B EV / Sales 2026
6.09x
EV / Sales 2027 * 5.55x
Free-Float
23.4%
Yield 2026
4%
Yield 2027 * 3.93%
1 day-1.79%
Current month-1.79%
1 month+12.24%
3 months+10.00%
Current year-6.78%
1 week 0.27
Extreme 0.27
0.28
1 month 0.24
Extreme 0.24
0.29
Current year 0.24
Extreme 0.235
0.31
1 year 0.24
Extreme 0.235
0.34
3 years 0.24
Extreme 0.235
0.38
5 years 0.24
Extreme 0.235
0.38
10 years 0.24
Extreme 0.235
0.38
Date Insider Type Main position Quantity % Market Cap.
3/18/26 Others

Chief Executive Officer

1,555,200,000 32.0000%
3/18/26 Others

Chief Executive Officer

1,555,200,000 32.0000%
1/27/26 Free

Chief Executive Officer

2,733,400 0.0562%
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%0.00%-6.78% - 332M
-1.28%-0.96%+20.30%+11.24% 218B
-0.71%-1.13%-4.02%-19.91% 142B
-1.68%+4.14%-17.85%+31.80% 139B
+0.27%+5.11%-49.76%+0.72% 75.11B
-1.04%+2.10%+17.05%+16.26% 52.8B
+0.69%-0.51%-16.49%-15.46% 50.66B
-0.51%+1.75%+24.61%+22.39% 41.95B
-0.32%+1.31%+41.37%+49.96% 40.49B
-0.14%+2.68%+0.40%+4.27% 33.28B
Average -0.65%+1.27%+0.88%+11.25% 79.38B
Weighted average by Cap. -0.82%+1.12%+0.50%+9.17%

Financials

2026 2027 *
Net sales 202M 49.49M 42.74M 40.16M 36.53M 68.67M 4.73B 69.81M 471M 184M 2.37B 186M 182M 7.87B 244M 59.75M 51.61M 48.5M 44.1M 82.92M 5.71B 84.29M 568M 222M 2.86B 224M 219M 9.51B
Net income 53.6M 13.12M 11.33M 10.65M 9.68M 18.2M 1.25B 18.5M 125M 48.78M 628M 49.25M 48.18M 2.09B 65.5M 16.03M 13.85M 13.01M 11.83M 22.25M 1.53B 22.61M 152M 59.6M 768M 60.19M 58.88M 2.55B
Net Debt - -
Logo Alpha IVF Group
Alpha IVF Group Bhd is a Malaysia-based fertility science, research, and advancement company. The company engages in the provision of assisted reproductive services through its specialist fertility care centers. The company offers access to comprehensive fertility services, technology, and labs across its fertility centers. Its assisted reproductive technologies (ART) refer to a range of medical technologies and treatments complemented with laboratory technologies and procedures to assist individuals or couples in overcoming the challenges of infertility. The company’s assisted reproductive services (ARS) include support services, such as fertility assessment, diagnostics and testing, monitoring, preconception care, and counseling. The medical technologies and treatments of ART are primarily carried out by medical specialists in obstetrics and gynecology, who are also responsible for the prescription of fertility and other related drugs.
Employees
-
Date Price Change Volume
26-08-16 MYR 0.2750 -1.79% 29,300
26-08-14 MYR 0.2800 +1.82% 1,295,000
26-08-13 MYR 0.2750 0.00% 156,500
26-08-12 MYR 0.2750 0.00% 2,573,400
26-08-11 MYR 0.2750 0.00% 567,000
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2800MYR
Average target price
0.3300MYR
Spread / Average Target
+17.86%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0303 Stock